T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.
Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P, Greenblatt JJ, Rosenberg SA, Klein H, Berger M, Mullen CA, Ramsey WJ, Muul L, Morgan RA, Anderson WF.
Blaese RM, et al. Among authors: chiang y.
Science. 1995 Oct 20;270(5235):475-80. doi: 10.1126/science.270.5235.475.
Science. 1995.
PMID: 7570001
Clinical Trial.